Literature DB >> 5479662

Familial lecithin: cholesterol acyltransferase deficiency. Study of two new patients and their close relatives.

K R Norum, S Borsting, I Grundt.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1970        PMID： 5479662

Source DB:  PubMed          Journal:  Acta Med Scand        ISSN： 0001-6101


× No keyword cloud information.
  7 in total

Review 1.  [Lecithin degradation and esterification of cholesterol in human serum. Further results on the role of lecithin-cholesterol acyltransferase in lipid metabolism under normal and pathological conditions (author's transl)].

Authors:  R Scherer
Journal:  Klin Wochenschr       Date:  1974-03-01

2.  Lipoproteins in LCAT-deficiency.

Authors:  G Utermann; W Schoenborn; K H Langer; P Dieker
Journal:  Humangenetik       Date:  1972

Review 3.  Reverse cholesterol transport: from classical view to new insights.

Authors:  Astrid-E van der Velde
Journal:  World J Gastroenterol       Date:  2010-12-21       Impact factor: 5.742

4.  Plasma lipoproteins in familial lecithin: cholesterol acyltransferase deficiency. Further studies of very low and low density lipoprotein abnormalities.

Authors:  J A Glomset; A V Nichols; K R Norum; W King; T Forte
Journal:  J Clin Invest       Date:  1973-05       Impact factor: 14.808

5.  Plasma lipoproteins in familial lecithin: cholesterol acyltransferase deficiency: physical and chemical studies of low and high density lipoproteins.

Authors:  K R Norum; J A Glomset; A V Nichols; T Forte
Journal:  J Clin Invest       Date:  1971-05       Impact factor: 14.808

6.  Genetic control of lecithin-cholesterol acyltransferase (LCAT): measurement of LCAT mass in a large kindred with LCAT deficiency.

Authors:  J J Albers; G Utermann
Journal:  Am J Hum Genet       Date:  1981-09       Impact factor: 11.025

7.  An analysis of lipoproteins, bile acids, and red cell membranes associated with target cells and spur cells in patients with liver disease.

Authors:  R A Cooper; M Diloy Puray; P Lando; M S Greenverg
Journal:  J Clin Invest       Date:  1972-12       Impact factor: 14.808
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.